Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2024 Nov 27;24(1):e16695. doi: 10.1111/jocd.16695

Risk Factors Associated With Facial Acne Scarring in Thai Patients With Acne: A Cross‐Sectional Study

Chadakan Yan 1, Phichayut Phinyo 1,2,3,, Yuri Yogya 4, Mati Chuamanochan 5, Rungsima Wanitphakdeedecha 6,
PMCID: PMC11704995  PMID: 39601200

ABSTRACT

Background

One of the worst long‐term effects of acne is scarring, which leads to significant physical, psychological, and economic burdens. Limited studies have specifically studied the risk factors for acne scarring. This study aims to explore risk factors associated with facial acne scarring in Thai patients with acne.

Methods

Exploratory cross‐sectional risk factor research was conducted using an online questionnaire on Thai patients aged ≥ 18 years who were diagnosed with acne between September and December 2023. The primary objective was to identify significant determinants of acne scars in patients with acne, including sociodemographic factors, clinical factors of acne, lifestyle factors, dietary habits factors, and treatment factors. Univariable and multivariable logistic regression were used to identify significant risk determinants.

Results

Of 225 patients with 61.33% prevalence of acne scarring, acne scarring was found to be independently associated with the following variables: moderate acne (mOR 3.51, 95% CI 1.31–9.40, p = 0.012) or severe‐to‐very severe acne (mOR 8.98, 95% CI 2.71–29.73, p < 0.001), sometimes squeezing and picking behaviors (mOR 2.69, 95% CI 2.71–29.73, p = 0.033), and postacne erythema (PAE) (mOR 4.46, 95% CI 1.96–10.14, p < 0.001).

Conclusion

The risk factors associated with acne scarring in individuals include the severity of acne, squeezing and picking behaviors, and experiencing PAE. One of this study's essential findings confirms that PAE is a notable component that could contribute to the development of acne scars. Early treatment of individuals at risk is crucial to reduce scar formation.

Keywords: acne, acne scar, acne scarring, acne vulgaris, risk factor

1. Introduction

Acne, usually called acne vulgaris, remains the most often treated inflammatory dermatosis worldwide [1]. The pathogenesis involves a complex interaction between hormonally induced sebum production, aberrant keratinization of the pilosebaceous duct, and immunological response to Cutibacterium acnes around the pilosebaceous unit [2]. The condition commonly develops during puberty, affecting nearly all adolescent boys (95%–100%) and a majority of teenage girls (83%–85%). It continues to persist in approximately 12%–14% of individuals throughout adulthood [3, 4].

One of the most severe sequelae of acne is scarring [5], a long‐lasting consequence that impacts nearly 95% of patients. Among acne patients, 47% get scars [6], and 30% have severe scarring [7, 8]. Acne's persistent nature and resulting scars cause substantial physical, psychological, psychological, social, and economic consequences [1]. Scars are formed due to an atypical healing response triggered by epidermal inflammation, resulting in an imbalance between matrix breakdown and collagen biosynthesis [9]. The development of scars can be categorized into two main stages: excessive tissue formation, resulting in keloid or hypertrophic scars, and tissue loss or destruction, leading to atrophic scars [5]. There are two main types of acne scars: hypertrophic scars/keloids and atrophic scars. Atrophic scars are observed in approximately 80%–90% of patients, and they are typically numerous [10]. The ice pick variety constitutes 60%–70% of atrophic scars, the boxcar accounts for 20%–30%, and the rolling variety comprises 15%–25% [11].

Society perceives facial acne scars as undesirable [12]. Few comprehensive studies have precisely examined the risk variables associated with acne scarring and the extent of its severity. Recent research validated the correlation between acne duration and treatment onset and showed that early treatment for inflammatory acne would effectively reduce the risk of physical and psychological scars [7, 13]. According to Heng et al. [6], family history and dietary habits were significant risk factors for developing acne, as well as its severity and potential scarring. There was a scarcity of studies that have mainly investigated the risk factors associated with acne scarring. Furthermore, no studies have examined the risk factors for acne scars within the Thai community. This study aimed to investigate the risk factors linked to acne and facial scarring in Thai individuals affected by acne. The results of this study will assist in formulating future approaches to diminish facial acne scarring in Thai acne patients and encourage timely intervention for individuals with a high susceptibility to scarring.

2. Methods

Exploratory risk factor research was conducted using a cross‐sectional design and a self‐reported questionnaire. The study's primary objective was to identify significant determinants of acne scars in Thai patients who responded to the survey between September and December 2023 in a dermatology outpatient clinic in a university hospital in Bangkok, Thailand, using convenient sampling. The inclusion criteria included Thai patients aged 18 years or older who were diagnosed with acne by physicians at the study site. The exclusion criteria were acne patients who could not read and upload clinical photos in the online questionnaire form. This study followed the Helsinki Declaration of 1964. The sample size calculation was based on data from previous relevant studies [5, 6, 7]. To achieve 80% statistical power and a two‐sided alpha error of 0.05 for identifying significant risk factors (i.e., gender, family history, the severity of acne, squeezing, and picking habits), at least 162 acne patients (75/87 in case/control) were required.

We collected all self‐reported demographic data and risk factors associated with postacne scarring from the literature review, including sociodemographic factors (age at acne onset [5], sex [5, 6], BMI [7], and family history of acne [6, 9]), clinical factors of acne (duration of acne [9], severity of acne [9], postacne erythema (PAE) [8], and squeezing and picking behaviors [9]), lifestyle factors (smoking/household smoker [7] and alcohol consumption [7]), dietary habits factors (butter consumption [6, 7], milk consumption [7], and cereal consumption [7]) and treatment factors (previous oral acne treatments [5] and previous topical acne treatments [5]). Each patient's clinical data and risk factors were collected from a self‐administered online questionnaire (using Google Forms). Photographs of the acne scar, levels of acne severity, and PAE were provided for respondents as an example of qualitative validation [9, 10]. To ensure the diagnosis of acne scarring, the clinical photo of the patient was validated by a dermatologist at the study site or the investigator via uploaded clinical photo (Y.Y.).

All statistical analyses were performed using Stata 17 (StataCorp, College Station, TX, USA). The normality of continuous data was examined by visualizing histograms. Continuous data regularly distributed was represented using the mean and standard deviation. Frequency and percentage were employed to characterize categorical data. Univariable and multivariable logistic regression were used to identify significant risk determinants. Odds ratios (OR), including univariable odds ratio (uOR) and multivariable odds ratio (mOR), along with their corresponding 95% confidence intervals (CI) for the risk factors associated with postacne scarring, were reported. As the objective was to explore independent risk factors, not to explain the causality of each factor, all factors within the multivariable model were presented regardless of their statistical significance. A p value of less than 0.05 was considered statistically significant.

3. Results

Two hundred twenty‐nine acne patients agreed to participate and responded to the online questionnaire. Four patients who did not complete the questionnaire were excluded. A total of 225 acne patients (98.25%) with the overall prevalence of acne scarring in the study site is 61.33% (case 138 persons/control 87 persons).

All demographic data and risk factors associated with postacne scarring, including sociodemographic factors, acne manifestation factors, lifestyle factors, dietary habits factors, and treatment factors, are shown in Table 1. Based on the univariable analysis, age at acne onset (≤ 15 years), family history of acne, the severity of acne (moderate to very severe), squeezing and picking behaviors, PAE, and treatment factors (previous topical and oral treatment) were found to be a risk factor for acne scarring (Table 1).

TABLE 1.

Clinical characteristics and univariable analysis of factors of individual factors associated with acne patients with acne scarring compared to those without acne scarring.

Clinical characteristics Acne patients with acne scarring (n = 138) Acne patients without acne scarring (n = 87) uOR (95% CI) p
n (%) or mean ± SD n (%) or mean ± SD
Sociodemographic factors
Age of acne onset
≤ 15 113 (81.88) 55 (63.22) 2.63 (1.42–4.86) 0.002
> 15 25 (18.12) 32 (36.78) 1.00 (Reference)
Sex
Female 88 (63.77) 61 (70.11) 1.00 (Reference)
Male 50 (36.23) 26 (29.89) 1.33 (0.75–2.37) 0.328
BMI (kg/m2) 22.21 ± 3.91 21.79 ± 3.56
< 18.5 18 (13.78) 13 (14.94) 1.00 (Reference)
18.5–23.0 79 (57.25) 51 (58.62) 1.11 (0.50–2.47) 0.782
> 23.0 41 (29.71) 23 (26.44) 1.28 (0.53–3.09) 0.572
Family history of acne 116 (84.06) 51 (58.62) 3.72 (1.99–6.95) < 0.001
Clinical factors of acne
Duration of acne (year)
< 10 26 (18.84) 18 (20.69) 1.00 (Reference)
≥ 10 112 (81.16) 69 (79.31) 1.12 (0.57–2.20) 0.734
Severity of acne
Almost clear, mild 41 (29.71) 73 (83.91) 1.00 (Reference)
Moderate 42 (30.43) 9 (10.34) 8.31 (3.68–18.78) < 0.001
Severe, very severe 55 (59.86) 5 (5.75) 19.59 (7.26–52.82) < 0.001
Squeezing and picking behaviors
Never, rarely 40 (28.99) 42 (48.28) 1.00 (Reference)
Sometimes 51 (36.96) 25 (28.74) 2.14 (1.12–4.08) 0.021
Frequently, all the time 47 (34.06) 20 (22.99) 2.47 (1.25–4.87) 0.009
Postacne erythema 114 (82.61) 27 (31.03) 10.56 (5.61–19.87) < 0.001
Lifestyle factors
Smoking/household smoker 23 (16.67) 13 (14.94) 1.14 (0.54–2.39) 0.731
Alcohol consumption 75 (54.35) 49 (56.32) 0.92 (0.53–1.58) 0.772
Dietary habits factors
Butter consumption
Never/occasionally 55 (39.86) 39 (44.83) 1.00 (Reference)
More than once/week 83 (60.14) 48 (55.17) 1.23 (0.71–2.11) 0.462
Milk consumption
Never/occasionally 27 (19.57) 17 (19.54) 1.00 (Reference)
More than once/week 111 (80.43) 70 (80.46) 0.99 (0.51–1.96) 0.996
Cereal consumption
Never/occasionally 76 (55.07) 38 (43.68) 1.00 (Reference)
More than once/week 62 (44.93) 49 (56.32) 0.63 (0.67–1.09) 0.097
Treatment factors
Previous topical acne treatments 119 (86.23) 45 (51.72) 5.85 (3.08–11.10) < 0.001
Previous oral acne treatments a 78 (56.52) 21 (24.14) 4.09 (2.25–7.41) < 0.001

Note: Statistically significant p‐value associations are shown in bold characters.

Abbreviations: BMI, body mass index; SD, standard deviation; uOR, univariable odds ratio.

a

Oral acne treatments included: antibiotics, oral contraceptives, and isotretinoin.

In multivariable analysis, the severity of acne (moderate to severe/very severe), squeezing and picking behaviors (sometimes), and PAE were identified as independent risk factors for acne scarring in multivariable analysis (Table 2). Severe‐to‐very severe acne severity showed the highest OR with mOR 8.98 (95% CI 2.71–29.73, p < 0.001) followed by PAE (mOR 4.46, 95% CI 1.96–10.14, p < 0.001), moderate acne severity (mOR 3.51, 95% CI 1.31–9.40, p = 0.012), and sometimes squeezing and picking behaviors (mOR 2.69, 95% CI 1.08–6.68, p = 0.033) (Table 2). Age at acne onset, family history of acne, squeezing and picking behaviors (frequently to all the time), and previous oral treatment showed no statistical significance after adjusting with all variables.

TABLE 2.

Multivariable analysis of individual factors associated with acne patients with acne scarring compared to acne patients without acne scarring.

Clinical characteristics mOR (95% CI) p
Sociodemographic factors
Age of acne onset
≤ 15 2.24 (0.97–5.15) 0.059
> 15 1.00 (Reference)
Sex
Female 1.00 (Reference)
Male 1.41 (0.56–3.56) 0.467
BMI (kg/m2)
< 18.5 1.00 (Reference)
18.5–23.0 1.52 (0.52–4.41) 0.446
> 23.0 1.57 (0.44–5.61) 0.486
Family history of acne 1.31 (0.56–3.07) 0.540
Clinical factors of acne
Duration of acne (year)
< 10 1.00 (Reference)
≥ 10 0.92 (0.34–2.47) 0.862
Severity of acne
Almost clear, mild 1.00 (Reference)
Moderate 3.51 (1.31–9.40) 0.012
Severe, very severe 8.98 (2.71–29.73) < 0.001
Squeezing and picking behaviors
Never, rarely 1.00 (Reference)
Sometimes 2.69 (1.08–6.68) 0.033
Frequently, All the time 2.05 (0.77–5.43) 0.150
Postacne erythema 4.46 (1.96–10.14) < 0.001
Lifestyle factors
Smoking/household smoker 0.72 (0.24–2.20) 0.567
Alcohol consumption 0.78 (0.36–1.73) 0.549
Dietary habits factors
Butter consumption
Never/occasionally 1.00 (Reference)
More than once/week 1.10 (0.45–2.71) 0.832
Milk consumption
Never/occasionally 1.00 (Reference)
More than once/week 0.50 (0.16–1.54) 0.227
Cereal consumption
Never/occasionally 1.00 (Reference)
More than once/week 0.90 (0.38–2.12) 0.804
Treatment factors
Previous topical acne treatments 2.16 (0.85–5.48) 0.106
Previous oral acne treatments 1.08 (0.46–2.56) 0.852

Note: Statistically significant p‐value associations are shown in bold characters.

Abbreviation: mOR, multivariable odds ratio.

4. Discussion

This study was an exploratory risk factor research using a cross‐sectional design to find the risk factors of acne scarring in Thai patients. The risk factors for acne scarring in acne patients were the severity of acne (moderate to severe/very severe), squeezing and picking behaviors (sometimes), and PAE. We discovered a prevalence of 61.33% for overall acne scars, comparable to the 53.6%–60.7% prevalence of acne scars in a Chinese Singaporean [6] and Chinese Malaysian [7], respectively.

The findings indicate that moderate‐to‐severe acne, behaviors such as squeezing and picking, and postacne erythema (PAE) are significant risk factors for acne scarring. Our results align with those of Tan J. et al. [9] and Liu L. et al. [11], who also identified acne severity and squeezing/picking behaviors as key contributors to scarring, with Liu et al. [11] reported ORs of 2.34 and 5.51 for moderate and severe acne, respectively. Severe acne often results in prolonged inflammation [11], leading to irreversible damage to sebaceous glands and increased scarring risk [12]. Recent studies corroborate that early treatment for inflammatory acne reduces the likelihood of scarring [13, 14]. PAE, characterized by persistent telangiectasia and erythematous lesions, results from the sustained release of inflammatory cytokines such as interleukin‐6 and TNF‐α [15]. Although PAE frequently diminishes over time, it can persist for months and contribute to scar formation [15]. Tan J. et al. [9] found a significant association between PAE and acne scarring, emphasizing the importance of early treatment. Our findings support the view that PAE is a significant risk factor for acne scarring, necessitating consideration in patient management.

No significant associations were found between acne scarring and age at onset, sex, BMI, or family history in multivariable analysis. Previous studies suggested that men are more prone to acne scars due to higher testosterone levels [16] and unique sebaceous gland structures [17]. Moreover, women were more prone than males to be self‐conscious of their appearance and to seek medical attention from their doctors for acne [11]. Our findings did not support a gender‐based difference in scarring risk which is in contrast with the results of a few studies [5, 6, 7, 11]. Certain indicators indicated that there may be a close relationship between genetic variables, such as highly heritable traits, and particular genetic susceptibility loci (such as selectin L and transforming growth factor beta 2) [18]. A family history of acne was a risk factor in univariable analysis but not in multivariable analysis contrary to some studies [5, 6].

Lifestyle factors such as smoking and alcohol consumption were not associated with acne scarring in our study, aligning with some previous research [5, 6] but conflicting with others, such as Say Y et al. [7], which found maternal smoking to be protective. The relationship between nutrition and acne remains debated, with some studies suggesting a link between dairy and high glycemic index diets and increased acne risk through the insulin‐like growth factor 1 (IGF1) signaling pathway [7], while others propose that omega‐3‐rich and low‐GI diets may offer protection [19]. Regarding treatment, our study did not find an association between acne scarring and the use of topical treatments like benzoyl peroxide, clindamycin, or topical isotretinoin. This contrasts with Dessinioti C. et al. [5], which found that oral acne treatments, such as antibiotics and isotretinoin, were associated with higher odds of scarring. Therefore, the influence of factors such as genetics, lifestyle, and treatment modalities requires further investigation.

In addition, we discovered a correlation with the severity of acne but not with its duration. The duration and severity of acne scarring may contribute to the affected individual's acne‐scar development [9]. Individuals who experience mild acne over an extended period may not develop acne scars, whereas those with extensive acne may develop them within a shorter timeframe. Further research is required to examine the correlation between the duration and severity of acne.

Our study has identified several risk factors for acne scarring in acne patients, including the severity of acne (ranging from moderate to extremely severe), the presence of squeezing and picking behaviors, and the potential role of PAE as critical factors that may contribute to the prevention of further acne aggravation and scar formation. Early acne treatment is strongly recommended for individuals with modifiable risk factors.

This study had some limitations. Firstly, the survey was self‐reported by the respondents. We overcame the incorrect diagnosis by self‐uploading the acne scar pictures on the face for dermatology validation. Secondly, recall bias can be found in previous acne history. Lastly, our study was conducted in a single study site, and mild severity of acne patients might have been missed in these cases from hospital visits, which can limit the generalizability of the results to the Thai population.

5. Conclusion

In conclusion, the risk factors associated with acne scarring in individuals include the severity of the acne, performing squeezing and picking behaviors, and experiencing PAE. One of this study's essential findings confirms that PAE is a notable component that could contribute to the development of acne scars. Our understanding of risk factors could aid in preventing or mitigating facial acne scarring and facilitate early treatment for those with a high susceptibility to scarring.

Author Contributions

All authors contributed to the study's conception and design. C.Y., P.P., M.C., and R.W. performed material preparation, data collection, and analysis. P.P., M.C., and R.W. had full access to all the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis. C.Y. and Y.Y. wrote the first draft of the manuscript, and all authors commented on previous versions. All authors read and approved the final manuscript. Authorship: All authors meet the International Committee of Medical Journal Editors criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Ethics Statement

The study was approved by the ethics committee of the Siriraj Institutional Review Board (SI 734/2023). This study followed the Helsinki Declaration of 1964 and its subsequent amendments.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

This study was partially supported by Chiang Mai University, the Faculty of Medicine, Chiang Mai University and the Faculty of Medicine Siriraj Hospital, Mahidol University.

Funding: The authors received no specific funding for this work.

[Correction added on 03 January 2025, after first online publication: Affiliations 5 and 6 have been transposed in this version.]

Contributor Information

Phichayut Phinyo, Email: phichayutphinyo@gmail.com.

Rungsima Wanitphakdeedecha, Email: rungsima.wan@mahidol.ac.th.

Data Availability Statement

The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.

References

  • 1. Layton A., Thiboutot D., and Tan J., “Reviewing the Global Burden of Acne: How Could We Improve Care to Reduce the Burden?,” British Journal of Dermatology 184, no. 2 (2021): 219–225. [DOI] [PubMed] [Google Scholar]
  • 2. Dréno B., “What Is New in the Pathophysiology of Acne, an Overview,” Journal of the European Academy of Dermatology and Venereology 31 (2017): 8–12. [DOI] [PubMed] [Google Scholar]
  • 3. Goodman G. J., “Postacne Scarring: A Review of Its Pathophysiology and Treatment,” Dermatologic Surgery 26, no. 9 (2000): 857–871. [DOI] [PubMed] [Google Scholar]
  • 4. Fabbrocini G., Annunziata M., D'arco V., et al., “Acne Scars: Pathogenesis, Classification and Treatment,” Dermatology Research and Practice 2010 (2010): 893080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Dessinioti C., Zisimou C., Platsidaki E., Katsambas A., and Antoniou C., “A Cross‐Sectional Study of Clinical Factors Associated With Acne Facial Scarring in Patients With Active Acne,” Journal of the European Academy of Dermatology and Venereology 32, no. 6 (2018): e212–e214. [DOI] [PubMed] [Google Scholar]
  • 6. Heng A. H. S., Say Y.‐H., Sio Y. Y., Ng Y. T., and Chew F. T., “Epidemiological Risk Factors Associated With Acne Vulgaris Presentation, Severity, and Scarring in a Singapore Chinese Population: A Cross‐Sectional Study,” Dermatology 238, no. 2 (2022): 226–235. [DOI] [PubMed] [Google Scholar]
  • 7. Say Y. H., Heng A. H. S., Reginald K., et al., “Modifiable and Non‐Modifiable Epidemiological Risk Factors for Acne, Acne Severity and Acne Scarring Among Malaysian Chinese: A Cross‐Sectional Study,” BMC Public Health 21, no. 1 (2021): 601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Tan J., Bourdès V., Bissonnette R., et al., “Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular Erythema,” Journal of Drugs in Dermatology 16, no. 6 (2017): 566–572. [PubMed] [Google Scholar]
  • 9. Tan J., Thiboutot D., Gollnick H., et al., “Development of an Atrophic Acne Scar Risk Assessment Tool,” Journal of the European Academy of Dermatology and Venereology: JEADV 31, no. 9 (2017): 1547–1554. [DOI] [PubMed] [Google Scholar]
  • 10. Elbuluk N., Grimes P., Chien A., et al., “The Pathogenesis and Management of Acne‐Induced Post‐Inflammatory Hyperpigmentation,” American Journal of Clinical Dermatology 22, no. 6 (2021): 829–836. [DOI] [PubMed] [Google Scholar]
  • 11. Liu L., Xue Y., Chen Y., et al., “Prevalence and Risk Factors of Acne Scars in Patients With Acne Vulgaris,” Skin Research and Technology 29, no. 6 (2023): e13386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Carlavan I., Bertino B., Rivier M., et al., “Atrophic Scar Formation in Patients With Acne Involves Long‐Acting Immune Responses With Plasma Cells and Alteration of Sebaceous Glands,” British Journal of Dermatology 179, no. 4 (2018): 906–917. [DOI] [PubMed] [Google Scholar]
  • 13. Layton A., Henderson C., and Cunliffe W., “A Clinical Evaluation of Acne Scarring and Its Incidence,” Clinical and Experimental Dermatology 19, no. 4 (1994): 303–308. [DOI] [PubMed] [Google Scholar]
  • 14. Tan J. K., Tang J., Fung K., et al., “Development and Validation of a Scale for Acne SCAR Severity (SCAR‐S) of the Face and Trunk,” Journal of Cutaneous Medicine and Surgery 14, no. 4 (2010): 156–160. [DOI] [PubMed] [Google Scholar]
  • 15. Amiri R., Khalili M., Mohammadi S., Iranmanesh B., and Aflatoonian M., “Treatment Protocols and Efficacy of Light and Laser Treatments in Post‐Acne Erythema,” Journal of Cosmetic Dermatology 21, no. 2 (2022): 648–656. [DOI] [PubMed] [Google Scholar]
  • 16. Ju Q., Tao T., Hu T., Karadağ A. S., Al‐Khuzaei S., and Chen W., “Sex Hormones and Acne,” Clinics in Dermatology 35, no. 2 (2017): 130–137. [DOI] [PubMed] [Google Scholar]
  • 17. Sugawara T., Nakagawa N., Shimizu N., Hirai N., Saijo Y., and Sakai S., “Gender‐ and Age‐Related Differences in Facial Sebaceous Glands in Asian Skin, as Observed by Non‐Invasive Analysis Using Three‐Dimensional Ultrasound Microscopy,” Skin Research and Technology: Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 25, no. 3 (2019): 347–354. [DOI] [PubMed] [Google Scholar]
  • 18. Common J. E. A., Barker J. N., and van Steensel M. A. M., “What Does Acne Genetics Teach Us About Disease Pathogenesis?,” British Journal of Dermatology 181, no. 4 (2019): 665–676. [DOI] [PubMed] [Google Scholar]
  • 19. Skroza N., Tolino E., Semyonov L., et al., “Mediterranean Diet and Familial Dysmetabolism as Factors Influencing the Development of Acne,” Scandinavian Journal of Public Health 40, no. 5 (2012): 466–474. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.


Articles from Journal of Cosmetic Dermatology are provided here courtesy of Wiley

RESOURCES